• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Purification and Proteomics of Influenza Virions

tetano

Editor, Senior Moderator
Methods Mol Biol. 2018;1836:89-120. doi: 10.1007/978-1-4939-8678-1_5.
[h=1]Purification and Proteomics of Influenza Virions.[/h] Hutchinson EC[SUP]1[/SUP], Stegmann M[SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] This chapter describes a basic workflow for analyzing the protein composition of influenza virions. In order to obtain suitable material, the chapter describes how to concentrate influenza virions from the growth media of infected cells and to purify them by ultracentrifugation through a density gradient. This approach is also suitable for purifying influenza virions from the allantoic fluid of embryonated chicken eggs. As a small quantity of microvesicles are co-purified with virions, optional steps are included to increase the stringency of purification by enriching material with viral receptor binding and cleaving activity. Material purified in this way can be used for a variety of downstream applications, including proteomics. As a detailed example of this, the chapter also describes a standard workflow for analyzing the protein composition of concentrated virions by liquid chromatography and tandem mass spectrometry.


[h=4]KEYWORDS:[/h] Influenza; LC-MS/MS; Mass spectrometry; MaxQuant; Proteomics; Ultracentrifugation; Virion

PMID: 30151570 DOI: 10.1007/978-1-4939-8678-1_5
 
Back
Top Bottom